[A case of Erdheim-Chester disease effectively treated by cyclophosphamide and prednisolone]

Nihon Kokyuki Gakkai Zasshi. 2007 Jan;45(1):43-8.
[Article in Japanese]

Abstract

Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis with a characteristic long bone lesion. Although about half of the patients have extraosseous organs, pulmonary involvement is very rare. We report a 55-year-old man with ECD who complained of severe dyspnea despite home oxygen therapy with noninvasive positive pressure ventilation. Continuous PGI2 administration was not very effective, but administration of cyclophosphamide and prednisolone induced rapid improvement of respiratory failure and the effect for six months on arterial blood gas analysis and stability of the disease state persisted.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Cyclophosphamide / administration & dosage*
  • Drug Therapy, Combination
  • Erdheim-Chester Disease / complications
  • Erdheim-Chester Disease / drug therapy*
  • Erdheim-Chester Disease / pathology
  • Humans
  • Male
  • Middle Aged
  • Prednisolone / administration & dosage*
  • Respiration Disorders / complications
  • Respiration Disorders / drug therapy

Substances

  • Anti-Inflammatory Agents
  • Cyclophosphamide
  • Prednisolone